시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 감각신경성 난청 치료 시장 보고서(2025년)
Sensorineural In Hearing Loss Disease Treatment Global Market Report 2025
상품코드 : 1769745
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,310,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,121,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,932,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감각신경성 난청 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.5%로 102억 4,000만 달러로 성장할 것으로 예상됩니다. 이 성장은 인공 내이 사용 증가, 개인화 치료에 대한 선호도 증가, 원격 오디오 로지 서비스 확대, 건강 관리 지출 증가, 소아 난청 관리의 중시 등으로 기대됩니다. 예측기간 중 중요한 동향으로는 재생치료의 진보, 청각진단에 있어서의 인공지능의 이용, 시판 보청기로의 이행, 바이오테크놀러지 기업과 청각 관련 기업의 제휴, 유전자 치료의 진전 등을 들 수 있습니다.

소음 공해 증가는 향후 감각신경성 난청 치료 시장의 성장을 가속할 것으로 예측됩니다. 소음 공해에는 인간의 건강과 야생동물, 전체 생활의 질에 해를 끼칠 수 있는 환경에서 과도한 소리와 방해음이 포함됩니다. 이러한 소음공해 증가는 교통기관이나 산업 활동 증가와 함께, 급속한 도시화에 의한 곳이 큽니다. 도시 지역이 확대됨에 따라 소음 수준을 유발하는 자동차, 건설 현장 및 공장 수가 증가합니다. 감각신경성 난청 치료는 청각 기능을 회복시키고 환경 소음으로 인한 장기적인 손상을 최소화하여 소음 공해의 부정적인 영향을 없애는 데 도움이 됩니다. 예를 들어 영국 환경청 보고서에 따르면 2022년 심각한 소음공해 발생 건수는 51건으로 2021년 50건에서 약간 증가했습니다. 따라서 소음 공해의 확대가 감각신경성 난청 치료 시장을 뒷받침하고 있습니다.

감각신경성 난청 치료 시장의 주요 기업은 청력 회복의 개선과 내이의 염증의 경감을 목적으로 한 경구 항염증 캡슐 등의 신제품을 개발하기 위한 임상시험에 주력하고 있습니다. 이 캡슐들은 내이를 포함한 체내 염증을 줄이기 위해 경구로 복용됩니다. 염증과 관련된 청각 세포에 대한 피해를 표적으로 함으로써 감음성 난청에 대처하고, 청각 기능을 높여 추가 악화를 방지할 수 있습니다. Sound Pharmaceuticals는 에브셀렌을 포함한 경구 항염증 캡슐 SPI-1005의 3상 임상시험이 성공적으로 종료되었다고 발표했습니다. STOPMD-3라고 불리는 이 임상시험에는 221명의 환자가 참여했으며 무작위 배정, 이중 맹검, 위약 대조를 거쳤습니다. 이 시험은 감음 난청의 일종인 메니에르병 환자의 저주파 청력 역치와 소음 환경 하에서의 단어 인식에 있어서 유의한 개선을 나타내, 유효성의 주요 평가 항목을 달성했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Sensorineural hearing loss treatment refers to addressing hearing impairment caused by damage to the inner ear (cochlea) or the auditory nerve connecting the ear to the brain. This damage disrupts the transmission of sound signals, leading to decreased hearing ability. Typically, this type of hearing loss is permanent and managed using hearing aids, cochlear implants, or other assistive technologies.

Key treatment options for sensorineural hearing loss include hearing aids, cochlear implants, corticosteroids, stem cell therapy, and tinnitus management devices. Hearing aids amplify sound electronically to help individuals with mild to moderate hearing loss. These devices are utilized for conditions such as presbycusis (age-related hearing loss), noise-induced hearing loss, sudden sensorineural hearing loss (SSNHL), congenital sensorineural hearing loss, and hearing loss caused by ototoxic drugs. They are commonly employed in settings like hospitals, otology clinics, and ambulatory care facilities.

The sensorineural hearing loss disease treatment market research report is one of a series of new reports from The Business Research Company that provides sensorineural hearing loss disease treatment market statistics, including the sensorineural hearing loss disease treatment industry global market size, regional shares, competitors with the sensorineural hearing loss disease treatment market share, detailed sensorineural hearing loss disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the sensorineural hearing loss disease treatment industry. These sensorineural hearing loss disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sensorineural in hearing loss disease treatment market size has grown strongly in recent years. It will grow from $6.78 billion in 2024 to $7.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The historical growth is driven by the aging population, rising noise pollution, increased occurrence of viral infections, broader newborn hearing screening initiatives, and heightened awareness of the benefits of early treatment.

The sensorineural in hearing loss disease treatment market size is expected to see strong growth in the next few years. It will grow to $10.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. This growth is expected due to the rising use of cochlear implants, growing preference for personalized medical treatments, expansion of tele-audiology services, increasing healthcare spending, and greater emphasis on managing hearing loss in children. Important trends during the forecast period include advancements in regenerative treatments, the use of artificial intelligence in hearing diagnostics, the move toward over-the-counter hearing aids, partnerships between biotechnology and audiology companies, and progress in gene therapy.

The rising noise pollution is expected to drive the growth of the sensorineural hearing loss disease treatment market in the future. Noise pollution involves excessive or disturbing sounds in the environment that can harm human health, wildlife, and overall quality of life. This increase in noise pollution is largely due to rapid urbanization along with the growth in transportation and industrial activities. As urban areas expand, the number of vehicles, construction sites, and factories contributing to noise levels rises. Treatments for sensorineural hearing loss help counteract the negative effects of noise pollution by restoring auditory function and minimizing the long-term damage caused by environmental noise. For example, a report from the Environmental Agency in the UK indicated that industrial sites were responsible for 51 serious noise pollution incidents in 2022, up slightly from 50 incidents in 2021. Hence, the growing noise pollution is propelling the market for sensorineural hearing loss treatments.

Key players in the sensorineural hearing loss disease treatment market are focusing on clinical trials to develop new products, such as oral anti-inflammatory capsules aimed at improving hearing restoration and reducing inner ear inflammation. These capsules are taken orally to reduce inflammation in the body, including in the inner ear. They address sensorineural hearing loss by targeting inflammation-related damage to auditory cells, potentially enhancing hearing function and preventing further deterioration. For instance, in December 2024, Sound Pharmaceuticals, Inc., a US-based company, announced the successful completion of its Phase 3 clinical trial for SPI-1005, an oral anti-inflammatory capsule containing ebselen. The trial, called STOPMD-3, included 221 patients and was randomized, double-blind, and placebo-controlled. It met its co-primary efficacy endpoints by showing significant improvements in low-frequency hearing thresholds and word recognition in noisy environments for patients with Meniere's Disease, a form of sensorineural hearing loss.

In September 2023, Regeneron Pharmaceuticals Inc., a US biotechnology firm focused on discovering and developing innovative medicines, acquired Decibel Therapeutics for an undisclosed sum. This acquisition is intended to enhance Regeneron's portfolio of genetic medicines by incorporating Decibel's expertise in gene therapies for hearing and balance disorders, particularly targeting congenital and monogenic sensorineural hearing loss. Decibel Therapeutics is a US-based biotech company specializing in gene therapies for hearing and balance conditions.

Major players in the sensorineural in hearing loss disease treatment market are Novartis AG, Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Contineum Therapeutics, Akouos Inc., Frequency Therapeutics, Sensorion, Myrtelle Inc., Heyu (Suzhou) Pharmaceutical Technology, Otonomy Inc., Acousia Therapeutics, Audion Therapeutics BV, Sound Pharmaceuticals Inc., Cilcare, Autifony Therapeutics Ltd., NeurAegis Inc., Prime Medicine Inc., ReNeuron Group Plc, Otonomy Inc., AudioCure Pharma.

North America was the largest region in the sensorineural in hearing loss disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sensorineural in hearing loss disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sensorineural in hearing loss disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sensorineural in hearing loss disease treatment market includes of revenues earned by entities by providing services such as hearing tests, audiological consultations, auditory rehabilitation and speech therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The sensorineural in hearing loss disease treatment market consists of sales of hearing aids, bone-anchored hearing systems, hearing aid batteries and cochlear implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sensorineural In Hearing Loss Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sensorineural in hearing loss disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sensorineural in hearing loss disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sensorineural in hearing loss disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Sensorineural In Hearing Loss Disease Treatment Market Characteristics

3. Sensorineural In Hearing Loss Disease Treatment Market Trends And Strategies

4. Sensorineural In Hearing Loss Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sensorineural In Hearing Loss Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Sensorineural In Hearing Loss Disease Treatment Market Segmentation

7. Sensorineural In Hearing Loss Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Sensorineural In Hearing Loss Disease Treatment Market

9. China Sensorineural In Hearing Loss Disease Treatment Market

10. India Sensorineural In Hearing Loss Disease Treatment Market

11. Japan Sensorineural In Hearing Loss Disease Treatment Market

12. Australia Sensorineural In Hearing Loss Disease Treatment Market

13. Indonesia Sensorineural In Hearing Loss Disease Treatment Market

14. South Korea Sensorineural In Hearing Loss Disease Treatment Market

15. Western Europe Sensorineural In Hearing Loss Disease Treatment Market

16. UK Sensorineural In Hearing Loss Disease Treatment Market

17. Germany Sensorineural In Hearing Loss Disease Treatment Market

18. France Sensorineural In Hearing Loss Disease Treatment Market

19. Italy Sensorineural In Hearing Loss Disease Treatment Market

20. Spain Sensorineural In Hearing Loss Disease Treatment Market

21. Eastern Europe Sensorineural In Hearing Loss Disease Treatment Market

22. Russia Sensorineural In Hearing Loss Disease Treatment Market

23. North America Sensorineural In Hearing Loss Disease Treatment Market

24. USA Sensorineural In Hearing Loss Disease Treatment Market

25. Canada Sensorineural In Hearing Loss Disease Treatment Market

26. South America Sensorineural In Hearing Loss Disease Treatment Market

27. Brazil Sensorineural In Hearing Loss Disease Treatment Market

28. Middle East Sensorineural In Hearing Loss Disease Treatment Market

29. Africa Sensorineural In Hearing Loss Disease Treatment Market

30. Sensorineural In Hearing Loss Disease Treatment Market Competitive Landscape And Company Profiles

31. Sensorineural In Hearing Loss Disease Treatment Market Other Major And Innovative Companies

32. Global Sensorineural In Hearing Loss Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sensorineural In Hearing Loss Disease Treatment Market

34. Recent Developments In The Sensorineural In Hearing Loss Disease Treatment Market

35. Sensorineural In Hearing Loss Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기